ASHLEY LAMB: Open Payments
NPI 1124274352 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 13 payments from 10 companies in 2025. Trend: 2023 $1,997 · 2024 $2,257 · 2025 $482
Food & beverage: $382Education: $100
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $138 |
| Janssen Biotech, Inc. | 1 | $100 |
| UCB, Inc. | 2 | $59 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| ABBVIE INC. | 1 | $29 |
| Incyte Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: NEMLUVIO, TREMFYA, Bimzelx, DUPIXENT, COSENTYX, SKYRIZI, OPZELURA, EBGLYSS.
Industry payments across NY — which companies pay providers there.
